Words of wisdom. Re: Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status.
University of Colorado, School of Medicine, Comprehensive Cancer Center, Aurora, CO, USA. Thomas.Flaig@ucdenver.edu
Thomas W
TW
Flaig
Dan
D
Theodorescu